News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
103 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
Bayer’s Former Head of Discovery Lands New CSO Gig at Shire
There are some changes taking place in the C-suites at Shire.
December 1, 2017
·
2 min read
·
Mark Terry
Drug Development
Why Bristol-Myers’ Future is Highly Dependent on These 2 Cancer Drugs
In an analysis of BMS’ recent clinical history, Industry analysts at Trefis noted that two oncology drugs will be key revenue drivers for the company.
December 1, 2017
·
2 min read
·
Alex Keown
Business
Why This 6-Employee Biotech’s Stock Jumped 2,000% in Just Three Days
The spike began after the six-person company announced it had entered into a multi-year services agreement with Merck KGaA.
December 1, 2017
·
2 min read
·
Alex Keown
Business
Human Longevity CEO Out After 11 Months on the Job
There’s been a major shakeup in the executive team at Human Longevity.
December 1, 2017
·
2 min read
·
Mark Terry
Biotech Bay
Why This Bay Area Heart Software Biotech Could Become Silicon Valley’s Newest Unicorn
HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans.
December 1, 2017
·
1 min read
Biotech Bay
Why Intuitive Surgical’s Stock Looks Just Like Google in 2004
Intuitive Surgical’s market cap currently stands at around $45 billion, not too far below where Google was in 2004.
December 1, 2017
·
1 min read
Business
Amazon in Exploratory Talks With Mylan, Novartis About Pharma Entry
Speculation has increased that Amazon might enter the pharmacy market after it conducted high-level talks with generic drug companies Mylan and Sandoz, a division of Novartis.
December 1, 2017
·
2 min read
·
Mark Terry
Deals
Siemens Healthineers’ Frankfurt IPO Could Bring in $12B Next Year
Siemens Healthineers, the German industrial conglomerate’s largest and most profitable division, is worth roughly $47.49 billion.
December 1, 2017
·
1 min read
BioCapital
3 Biotechs to Load Up on This Holiday Season
These great biotech stocks to buy for the holidays come in all sizes -- small-cap, mid-cap, and large-cap.
December 1, 2017
·
1 min read
Zhenxing Biopharma, a Plasma Company, Sells 19% Stake for $322M
Zhenxing Biopharma raised $322M by selling a 19% share of the company to Kaisa Group Holdings.
December 1, 2017
·
1 min read
1 of 11
Next
